Company / Current Assets
MAXCYTE, INC. Current Assets History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$118.4M
FY2025
5-year range
$118.4M / $270.4M
FY2021-FY2025
Trend
-31.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has declined for 4 consecutive years, from $270M in FY2021 to $118M in FY2025.
Based on SEC 10-K filings.
$118M in FY2025 with a 3-year CAGR of -22.3%.
Declined from $190M to $118M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -22.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- MAXCYTE, INC.'s current assets has declined for 4 consecutive years.
- 3-year CAGR of -22.3%, indicating a declining trend.
- In FY2025, current assets decreased 31.1% year-over-year.
- Peak current assets was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.96 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $118.4M | -31.1% |
| FY2024 | $171.7M | -9.7% |
| FY2023 | $190.2M | -24.6% |
| FY2022 | $252.3M | -6.7% |
| FY2021 | $270.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026